Latest Strategic Expansion News

EVE Health Group has successfully passed all shareholder resolutions at its recent General Meeting, paving the way for its acquisition of Nextract Pty Ltd and announcing significant leadership changes.

Streamplay’s subsidiary Noodlecake has inked a three-year licensing agreement with Amazon to adapt and distribute one of its owned games on Amazon’s gaming platform, marking a strategic expansion into a new marketplace.

Regal Partners Limited reported a stellar 2024 with a 141% jump in average funds under management to $14.4 billion and a near tripling of net profit after tax. Strategic acquisitions and offshore expansion underpin its growth trajectory.

Epsilon Healthcare has emerged from Administration, securing expanded medicinal cannabis manufacturing permits and launching a new pharmacy brand as part of a strategic turnaround and growth plan.

Podium Minerals Limited has launched a fully underwritten $2.6 million entitlement offer to fund advanced metallurgical testing at its flagship Parks Reef Project, aiming to enhance platinum group metals recovery and concentrate grades.

NoviqTech and Livium have partnered to digitise and tokenise the environmental benefits of battery recycling, aiming to enhance transparency and compliance in the critical minerals supply chain.

Godolphin Resources has revealed promising high-grade gold and copper assays from two new prospects outside its established Lewis Ponds resource, signaling significant potential for resource expansion.

Aurum Resources has secured a joint venture to earn up to 80% interest in two new exploration permits adjacent to its 1.6Moz Boundiali Gold Project in Côte d'Ivoire, significantly expanding its landholding and growth potential.

InFocus Group Holdings has secured a $3.25 million contract to develop a cutting-edge white-label iGaming platform for Taiwanese firm TG Solutions, marking a significant expansion into the digital gaming sector.

ALS Limited delivered a robust FY25 performance with 16% revenue growth to $3 billion and underlying EBIT rising 4.7% to $515 million, driven by strong organic growth and strategic acquisitions. The company is advancing its Nuvisan integration ahead of schedule and has unveiled a $230 million investment plan to expand key laboratories, positioning itself for sustained growth amid market uncertainties.

ALS Limited reported a robust FY25 with $3 billion revenue driven by Life Sciences growth and resilient Commodities, announcing a $350 million equity raise to fund strategic expansion.

Askari Metals has launched Phase I exploration on its EPL 7626 licence at the Uis Project in Namibia, aiming to uncover polymetallic mineralisation including lithium, tin, and tantalum. The program leverages advanced remote sensing and rapid on-site analysis technologies to identify buried pegmatite targets.